Neuberger Berman and KKR Acquire Minority Stake in Datavant

Key Facts

In a move reflecting the continued flow of investment capital into the health-tech sector, Neuberger Berman and KKR have announced the acquisition of a minority stake in Datavant. According to reports, this investment is designed to support Datavant’s expansion within the healthcare data connectivity market, leveraging the capital and global expertise of both investment firms. The partnership aims to strengthen the company’s position in providing specialized data solutions for the medical industry.

This transaction occurs as the private equity sector shows increasing interest in specialized technology firms, with KKR and Neuberger Berman seeking to diversify their portfolios through strategic holdings. Based on market dynamics, this move signals institutional confidence in the long-term growth of digital healthcare data solutions. While specific financial terms were not disclosed, the deal aligns with the minority stake acquisition strategies frequently employed by these major global funds.

Looking ahead, investment circles are monitoring how this capital infusion will accelerate innovation at Datavant in the coming period. With direct instrument price data unavailable as of the close on September 15, 2026, market focus remains on the broader performance of the healthcare technology sector. Investors will also watch for future updates in the economic calendar regarding the financial services sector or major institutional investment shifts.